Immunology sponsored testing programs 

Invitae partners with biopharma companies to offer sponsored testing for patients who meet eligibility criteria


Pharming Healthcare, Inc. has partnered with Invitae to offer sponsored, no-charge genetic testing and counseling for individuals who may carry a pathogenic variant in one of two genes known to be associated with Activated PI3K Delta Syndrome (APDS), a rare Primary Immunodeficiency.

The navigateAPDS testing program may help eliminate barriers to genetic testing and increase certainty in obtaining a correct diagnosis by enabling patients suspected of having APDS, and their family members, to have access to genetic testing and counseling.


Rare primary immunodeficiencies, congenital neutropenia, WHIM syndrome

X4 Pharmaceuticals, Inc. has partnered with Invitae to offer third-party sponsored genetic testing at no charge for individuals who may carry a genetic mutation known to be associated with congenital neutropenia. Primary immunodeficiencies are a group of inherited disorders of the immune system including congenital neutropenia and WHIM syndrome.